@article{90bdbfc05c7a458698758ebbe725a80a,
title = "Acoramidis for Transthyretin Amyloid Cardiomyopathy: Open-Label Extension Study Long-Term Follow-Up",
keywords = "ATTR-CM, Heart failure, cardiac pathology, cardiovascular disease, clinical trials acoramidis, safety, serum TTR",
author = "AHMAD MASRI and MANDAR ARAS and MARTHA GROGAN and DANIEL JACOBY and MAURER, \{MATHEW S.\} and SHAH, \{SANJIV J.\} and RONALD WITTELES and WONG, \{PAUL W.\} and JI, \{ALAN X.\} and DU, \{J. I.N.G.\} and SURESH SIDDHANTI and LEONID KATZ and SINHA, \{U. M.A.\} and FOX, \{JONATHAN C.\} and JUDGE, \{DANIEL P.\}",
year = "2025",
month = aug,
doi = "10.1016/j.cardfail.2025.03.017",
language = "English (US)",
volume = "31",
pages = "1354--1359",
journal = "Journal of Cardiac Failure",
issn = "1071-9164",
publisher = "Elsevier B.V.",
number = "8",
}